Correlation Between CERo Therapeutics and New Relic
Can any of the company-specific risk be diversified away by investing in both CERo Therapeutics and New Relic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CERo Therapeutics and New Relic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CERo Therapeutics Holdings and New Relic, you can compare the effects of market volatilities on CERo Therapeutics and New Relic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CERo Therapeutics with a short position of New Relic. Check out your portfolio center. Please also check ongoing floating volatility patterns of CERo Therapeutics and New Relic.
Diversification Opportunities for CERo Therapeutics and New Relic
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between CERo and New is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding CERo Therapeutics Holdings and New Relic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on New Relic and CERo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CERo Therapeutics Holdings are associated (or correlated) with New Relic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of New Relic has no effect on the direction of CERo Therapeutics i.e., CERo Therapeutics and New Relic go up and down completely randomly.
Pair Corralation between CERo Therapeutics and New Relic
If you would invest 7,164 in New Relic on September 22, 2024 and sell it today you would earn a total of 0.00 from holding New Relic or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 4.76% |
Values | Daily Returns |
CERo Therapeutics Holdings vs. New Relic
Performance |
Timeline |
CERo Therapeutics |
New Relic |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
CERo Therapeutics and New Relic Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CERo Therapeutics and New Relic
The main advantage of trading using opposite CERo Therapeutics and New Relic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CERo Therapeutics position performs unexpectedly, New Relic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in New Relic will offset losses from the drop in New Relic's long position.CERo Therapeutics vs. Viking Therapeutics | CERo Therapeutics vs. Vanda Pharmaceuticals | CERo Therapeutics vs. Verrica Pharmaceuticals | CERo Therapeutics vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |